Pfizer enrolls over 42,000 patients for COVID-19 vaccine trial
Almost 36K, of 42K total patients, have received their second dose as of Oct. 26, Pfizer said
Almost 36K, of 42K total patients, have received their second dose as of Oct. 26, Pfizer said